AVADEL PHARMACEUTICALS PLC financial data

Symbol
AVDL on Nasdaq
Location
Dublin 2
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276% % -9.3%
Quick Ratio 40% % 34%
Debt-to-equity 113% % 4.6%
Return On Equity 23% %
Return On Assets 11% %
Operating Margin 1.8% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97,656,664 shares 1.3%
Common Stock, Shares, Outstanding 97,235,000 shares 0.93%
Entity Public Float $1,342,171,790 USD -8%
Common Stock, Value, Issued $972,000 USD 0.94%
Weighted Average Number of Shares Outstanding, Basic 97,104,000 shares 0.84%
Weighted Average Number of Shares Outstanding, Diluted 101,276,000 shares 5.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $248,517,000 USD 80%
Research and Development Expense $39,893,000 USD 200%
Operating Income (Loss) $4,524,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,846,000 USD 95%
Income Tax Expense (Benefit) $2,977,000 USD -596%
Net Income (Loss) Attributable to Parent $19,702,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $79,813,000 USD 179%
Marketable Securities, Current $11,764,000 USD -68%
Accounts Receivable, after Allowance for Credit Loss, Current $42,444,000 USD 14%
Inventory, Net $23,905,000 USD 49%
Other Assets, Current $798,000 USD -59%
Assets, Current $172,226,000 USD 35%
Property, Plant and Equipment, Net $467,000 USD -0.43%
Operating Lease, Right-of-Use Asset $2,544,000 USD 32%
Goodwill $16,836,000 USD 0%
Other Assets, Noncurrent $7,375,000 USD -37%
Assets $199,448,000 USD 26%
Accounts Payable, Current $12,581,000 USD 59%
Accrued Liabilities, Current $44,156,000 USD 30%
Liabilities, Current $62,487,000 USD 46%
Operating Lease, Liability, Noncurrent $1,810,000 USD 49%
Other Liabilities, Noncurrent $2,098,000 USD -59%
Liabilities $101,223,000 USD 21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $23,576,000 USD 0.95%
Retained Earnings (Accumulated Deficit) $789,562,000 USD -0.04%
Stockholders' Equity Attributable to Parent $98,225,000 USD 32%
Liabilities and Equity $199,448,000 USD 26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,232,000 USD 72%
Net Cash Provided by (Used in) Financing Activities $690,000 USD -95%
Net Cash Provided by (Used in) Investing Activities $12,317,000 USD -42%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 97,235,000 shares 0.93%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,999,000 USD 8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $79,813,000 USD 179%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,890,000 USD 159%
Deferred Tax Assets, Valuation Allowance $101,565,000 USD 5.3%
Deferred Tax Assets, Gross $101,565,000 USD 5.3%
Operating Lease, Liability $1,704,000 USD -35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $52,000 USD 100%
Lessee, Operating Lease, Liability, to be Paid $1,953,000 USD -36%
Operating Lease, Liability, Current $740,000 USD 2.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $477,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year One $683,000 USD -37%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $249,000 USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Three $477,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $68,568,000 USD -3.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $2,724,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year Four $316,000 USD -34%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%